). M. Youden-index and J. P. Quenot, A significant difference was measured between the EPIdemiology of Septic Shock (EPISS) Study Group. (2013) Profile of the risk of death after septic shock in the present era: an epidemiologic study, Crit. Care Med, vol.41, pp.2600-2609

M. M. Levy, A. Artigas, G. S. Phillips, A. Rhodes, R. Beale et al., Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study, The Lancet Infectious Diseases, vol.12, issue.12, pp.919-924, 2012.
DOI : 10.1016/S1473-3099(12)70239-6

R. S. Hotchkiss, G. Monneret, and D. Payen, Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach, The Lancet Infectious Diseases, vol.13, issue.3, pp.260-268, 2013.
DOI : 10.1016/S1473-3099(13)70001-X

B. Amulic, C. Cazalet, G. L. Hayes, K. D. Metzler, and A. Zychlinsky, Neutrophil Function: From Mechanisms to Disease, Annual Review of Immunology, vol.30, issue.1, pp.459-489, 2012.
DOI : 10.1146/annurev-immunol-020711-074942

K. A. Brown, S. D. Brain, J. D. Pearson, J. D. Edgeworth, S. M. Lewis et al., Neutrophils in development of multiple organ failure in sepsis, The Lancet, vol.368, issue.9530, pp.157-169, 2006.
DOI : 10.1016/S0140-6736(06)69005-3

M. A. Kovach and T. J. Standiford, The function of neutrophils in sepsis, Current Opinion in Infectious Diseases, vol.25, issue.3, pp.321-327, 2012.
DOI : 10.1097/QCO.0b013e3283528c9b

J. Pillay, V. M. Kamp, E. Van-hoffen, T. Visser, T. Tak et al., A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1, Journal of Clinical Investigation, vol.122, issue.1, pp.327-336, 2012.
DOI : 10.1172/JCI57990DS1

R. C. Bone, R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM Consensus Conference Committee, pp.1644-1655, 1992.
DOI : 10.1378/chest.101.6.1644

J. Demaret, A. Walencik, M. C. Jacob, J. F. Timsit, F. Venet et al., Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples, Cytometry Part B: Clinical Cytometry, vol.188, issue.1, pp.59-62, 2013.
DOI : 10.1002/cyto.b.21043

F. Venet, A. C. Lukaszewicz, D. Payen, R. Hotchkiss, and G. Monneret, Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies, Current Opinion in Immunology, vol.25, issue.4, pp.477-483, 2013.
DOI : 10.1016/j.coi.2013.05.006

F. Venet, C. S. Chung, H. Kherouf, A. Geeraert, C. Malcus et al., Increased circulating regulatory T cells (CD4+CD25+CD127???) contribute to lymphocyte anergy in septic shock patients, Intensive Care Medicine, vol.71, issue.4, pp.678-686, 2009.
DOI : 10.1007/s00134-008-1337-8

E. Guérin, M. Orabona, M. A. Raquil, B. Giraudeau, R. Bellier et al., Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration*, Critical Care Medicine, vol.42, issue.9, 2007.
DOI : 10.1097/CCM.0000000000000344

R. S. Hotchkiss, C. M. Coopersmith, J. E. Mcdunn, and T. A. Ferguson, The sepsis seesaw: tilting toward immunosuppression, Nature Medicine, vol.177, issue.5, pp.496-497, 2009.
DOI : 10.1073/pnas.0809422106

R. S. Hotchkiss, G. Monneret, and D. Payen, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nature Reviews Immunology, vol.12, issue.12, pp.862-874, 2013.
DOI : 10.1038/nri3552

Y. Orr, J. M. Taylor, P. G. Bannon, C. Geczy, and L. Kritharides, Circulating CD10-/CD16low neutrophils provide a quantitative index of active bone marrow neutrophil release, British Journal of Haematology, vol.84, issue.4, pp.508-519, 2005.
DOI : 10.1097/00024382-200301000-00002

G. Drifte, I. Dunn-siegrist, P. Tissì-eres, and J. Pugin, Innate Immune Functions of Immature Neutrophils in Patients With Sepsis and Severe Systemic Inflammatory Response Syndrome*, Critical Care Medicine, vol.41, issue.3, pp.820-832, 2013.
DOI : 10.1097/CCM.0b013e318274647d

B. M. Tavares-murta, M. Zaparoli, R. B. Ferreira, M. L. Silva-vergara, C. H. Oliveira et al., Failure of neutrophil chemotactic function in septic patients*, Critical Care Medicine, vol.30, issue.5, pp.1056-1061, 2002.
DOI : 10.1097/00003246-200205000-00017

P. S. Martins, M. K. Brunialti, L. S. Martos, F. R. Machado, M. S. Assunçao et al., Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis, Critical Care, vol.12, issue.1, p.25, 2008.
DOI : 10.1186/cc6801

P. S. Martins, E. G. Kallas, M. C. Neto, M. A. Dalboni, S. Blecher et al., Upregulation of Reactive Oxygen Species Generation and Phagocytosis, and Increased Apoptosis in Human Neutrophils During Severe Sepsis and Septic Shock, Shock, vol.20, issue.3, pp.208-212, 2003.
DOI : 10.1097/01.shk.0000079425.52617.db

A. K. Schröder and L. Rink, Neutrophil immunity of the elderly, Mechanisms of Ageing and Development, vol.124, issue.4, pp.419-425, 2003.
DOI : 10.1016/S0047-6374(03)00017-4

C. W. Tseng and G. Y. Liu, Expanding roles of neutrophils in aging hosts, Current Opinion in Immunology, vol.29, pp.43-48, 2014.
DOI : 10.1016/j.coi.2014.03.009

I. Wessels, J. Jansen, L. Rink, and P. Uciechowski, Immunosenescence of Polymorphonuclear Neutrophils, The Scientific World JOURNAL, vol.10, pp.145-160, 2010.
DOI : 10.1100/tsw.2010.14

G. Monneret, F. Venet, A. Pachot, and A. Lepape, Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony

R. Hotchkiss and S. Opal, Immunotherapy for Sepsis ??? A New Approach against an Ancient Foe, New England Journal of Medicine, vol.363, issue.1, pp.87-89, 2010.
DOI : 10.1056/NEJMcibr1004371

W. Docke, F. Randow, U. Syrbe, D. Krausch, K. Asadullah et al., Monocyte deactivation in septic patients: Restoration by IFN-?? treatment, Nature Medicine, vol.7, issue.6, pp.678-681, 1997.
DOI : 10.1097/00003246-199607000-00010

G. Nakos, V. Malamou-mitsi, A. Lachana, A. Karassavoglou, E. Kitsiouli et al., Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-??*, Critical Care Medicine, vol.30, issue.7, pp.1488-1494, 2002.
DOI : 10.1097/00003246-200207000-00015

C. Meisel, J. Schefold, R. Pschowski, T. Baumann, K. Hetzger et al., Granulocyte???Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.7, pp.640-648, 2009.
DOI : 10.1164/rccm.200903-0363OC

K. Wolk, W. Docke, V. Von-baehr, H. Volk, and R. Sabat, Impaired antigen presentation by human monocytes during endotoxin tolerance, Blood, vol.96, pp.218-223, 2000.

G. Monneret, A. Lepape, N. Voirin, J. Bohe, F. Venet et al., Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock, Intensive Care Medicine, vol.51, issue.8, pp.1175-1183, 2006.
DOI : 10.1007/s00134-006-0204-8

URL : https://hal.archives-ouvertes.fr/hal-00428008

C. Landelle, A. Lepape, N. Voirin, E. Tognet, F. Venet et al., Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock, Intensive Care Medicine, vol.51, issue.11, pp.1859-1866, 2010.
DOI : 10.1007/s00134-010-1962-x

URL : https://hal.archives-ouvertes.fr/hal-00539253

F. Venet, S. Tissot, A. Debard, C. Faudot, C. Crampe et al., Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock, Critical Care Medicine, vol.35, issue.8, pp.1910-1917, 2007.
DOI : 10.1097/01.CCM.0000275271.77350.B6

A. Cheron, B. Floccard, B. Allaouchiche, C. Guignant, F. Poitevin et al., Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma, Critical Care, vol.14, issue.6, p.208, 2010.
DOI : 10.1186/cc9331

G. Monneret, N. Elmenkouri, J. Bohe, A. Debard, M. Gutowski et al., Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to the monitoring of patients with septic shock, Clin Chem, vol.48, pp.1589-1592, 2002.

W. Docke, C. Hoflich, K. Davis, K. Rottgers, C. Meisel et al., Monitoring Temporary Immunodepression by Flow Cytometric Measurement of Monocytic HLA-DR Expression: A Multicenter Standardized Study, Clinical Chemistry, vol.51, issue.12, pp.2341-2347, 2005.
DOI : 10.1373/clinchem.2005.052639

A. Lukaszewicz, M. Grienay, M. Resche-rigon, R. Pirracchio, V. Faivre et al., Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction*, Critical Care Medicine, vol.37, issue.10, pp.2746-2752, 2009.
DOI : 10.1097/CCM.0b013e3181ab858a

H. Maecker, J. Mccoy, J. Amos, M. Elliott, J. Gaigalas et al., A model for harmonizing flow cytometry in clinical trials, Nature Immunology, vol.73, issue.11, pp.975-978, 2010.
DOI : 10.1016/j.immuni.2009.09.007

F. Venet, A. Lepape, and G. Monneret, Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions, Critical Care, vol.15, issue.5, p.231, 2012.
DOI : 10.1056/NEJMcibr1004371

D. Jaye, R. Bray, H. Gebel, W. Harris, E. Waller et al., Translational Applications of Flow Cytometry in Clinical Practice, The Journal of Immunology, vol.188, issue.10, pp.4715-4719, 2012.
DOI : 10.4049/jimmunol.1290017

H. Maecker, J. Mccoy, and R. Nussenblatt, Standardizing immunophenotyping for the Human Immunology Project, Nat Rev Immunol, vol.12, pp.191-200, 2012.

O. Perez, D. Mitchell, R. Campos, G. Gao, L. Li et al., Multiparameter Analysis of Intracellular Phosphoepitopes in Immunophenotyped Cell Populations by Flow Cytometry, Curr Protoc Cytom, vol.98, issue.6, p.20, 2005.
DOI : 10.1002/0471142956.cy0620s32

C. Baecher-allan and D. Hafler, Human regulatory T cells and their role in autoimmune disease, Immunological Reviews, vol.172, issue.1, pp.203-216, 2006.
DOI : 10.1084/jem.20032069

K. Wood, A. Bushell, and J. Hester, Regulatory immune cells in transplantation, Nature Reviews Immunology, vol.21, issue.6, pp.417-430, 2012.
DOI : 10.1038/nri3227

G. Monneret and F. Venet, Additional bad news from regulatory T cells in sepsis, Critical Care, vol.14, issue.6, p.453, 2010.
DOI : 10.1186/cc9357

N. Erfani, S. Mehrabadi, M. Ghayumi, M. Haghshenas, Z. Mojtahedi et al., Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC), Lung Cancer, vol.77, issue.2, pp.306-311, 2012.
DOI : 10.1016/j.lungcan.2012.04.011

S. Elahi, W. Dinges, N. Lejarcegui, K. Laing, A. Collier et al., Protective HIV-specific CD8+ T cells evade Treg cell suppression, Nature Medicine, vol.173, issue.8, pp.989-995, 2011.
DOI : 10.1016/j.jim.2007.03.002

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324980

T. Fukaya, H. Takagi, Y. Sato, K. Sato, K. Eizumi et al., Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance, Blood, vol.116, issue.13, pp.2266-2276, 2010.
DOI : 10.1182/blood-2009-10-250472

URL : https://hal.archives-ouvertes.fr/hal-00605852

S. Sakaguchi, M. Miyara, C. Costantino, and D. Hafler, FOXP3+ regulatory T cells in the human immune system, Nature Reviews Immunology, vol.34, issue.7, pp.490-500, 2010.
DOI : 10.1038/nri2785

J. Fontenot, M. Gavin, and A. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nature Immunology, vol.4, issue.4, pp.330-336, 2003.
DOI : 10.1038/ni904

J. Saison, J. Demaret, F. Venet, C. Chidiac, C. Malcus et al., CD4þCD25þCD127-assessment as a surrogate phenotype for FOXP3þ regulatory T cells in HIV-1 infected viremic and aviremic subjects, Cytometry B Clin Cytom, vol.84, pp.50-54, 2013.

F. Lanza, Toward standardization of Foxp3þ regulatory T-cell measurement in clinical settings, Cytometry B Clin Cytom, vol.76, pp.67-68, 2009.

M. Levy, M. Fink, J. Marshall, E. Abraham, D. Angus et al., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, ATS/SIS International Sepsis Definitions Conference, pp.1250-1256, 2001.
DOI : 10.1097/01.CCM.0000050454.01978.3B

F. Venet, C. Chung, H. Kherouf, A. Geeraert, C. Malcus et al., Increased circulating regulatory T cells (CD4+CD25+CD127???) contribute to lymphocyte anergy in septic shock patients, Intensive Care Medicine, vol.71, issue.4, pp.678-686, 2009.
DOI : 10.1007/s00134-008-1337-8

T. Duhen, R. Duhen, A. Lanzavecchia, F. Sallusto, and D. Campbell, Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells, Blood, vol.119, issue.19, pp.4430-4440, 2012.
DOI : 10.1182/blood-2011-11-392324

F. Simonetta, C. Lecuroux, I. Girault, C. Goujard, M. Sinet et al., Early and Long-Lasting Alteration of Effector CD45RA-Foxp3high Regulatory T-Cell Homeostasis During HIV Infection, Journal of Infectious Diseases, vol.205, issue.10, pp.1510-1519, 2012.
DOI : 10.1093/infdis/jis235

URL : https://hal.archives-ouvertes.fr/inserm-00865957

J. Grant, K. Bourcier, S. Wallace, D. Pan, A. Conway et al., Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients, Cytometry Part B: Clinical Cytometry, vol.81, issue.2, pp.69-78, 2009.
DOI : 10.1002/cyto.b.20446

D. Tran, H. Ramsey, and E. Shevach, Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-?? dependent but does not confer a regulatory phenotype, Blood, vol.110, issue.8, pp.2983-2990, 2007.
DOI : 10.1182/blood-2007-06-094656

R. 1. Angus, D. C. Van-der-poll, and T. , Severe Sepsis and Septic Shock, New England Journal of Medicine, vol.369, issue.9, pp.840-851, 2013.
DOI : 10.1056/NEJMra1208623

M. M. Levy, A. Artigas, G. S. Phillips, A. Rhodes, R. Beale et al., Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study, The Lancet Infectious Diseases, vol.12, issue.12, pp.919-924, 2012.
DOI : 10.1016/S1473-3099(12)70239-6

R. S. Hotchkiss, G. Monneret, and D. Payen, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nature Reviews Immunology, vol.12, issue.12, pp.862-874, 2013.
DOI : 10.1038/nri3552

Y. Rochman, R. Spolski, and W. J. Leonard, New insights into the regulation of T cells by ??c family cytokines, Nature Reviews Immunology, vol.223, issue.7, pp.480-490, 2009.
DOI : 10.1038/nri2580

Y. Lévy, I. Sereti, G. Tambussi, J. P. Routy, J. D. Lelì-evre et al., Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study, Clinical Infectious Diseases, vol.55, issue.2, pp.291-300, 2012.
DOI : 10.1093/cid/cis383

C. L. Mackall, T. J. Fry, and R. E. Gress, Harnessing the biology of IL-7 for therapeutic application, Nature Reviews Immunology, vol.44, issue.5, pp.330-342, 2011.
DOI : 10.1038/nri2970

C. Sportès, R. R. Babb, M. C. Krumlauf, F. T. Hakim, S. M. Steinberg et al., Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy, Clinical Cancer Research, vol.16, issue.2, pp.727-735, 2010.
DOI : 10.1158/1078-0432.CCR-09-1303

R. S. Hotchkiss and L. L. Moldawer, Parallels between cancer and infectious disease, N. Engl. J. Med, vol.371, pp.380-383, 2014.

F. Venet, A. P. Foray, A. Villars-méchin, C. Malcus, F. Poitevin-later et al., IL-7 Restores Lymphocyte Functions in Septic Patients, The Journal of Immunology, vol.189, issue.10, pp.5073-5081, 2012.
DOI : 10.4049/jimmunol.1202062

J. Unsinger, C. A. Burnham, J. Mcdonough, M. Morre, P. S. Prakash et al., Interleukin-7 Ameliorates Immune Dysfunction and Improves Survival in a 2-Hit Model of Fungal Sepsis, Journal of Infectious Diseases, vol.206, issue.4, pp.606-616, 2012.
DOI : 10.1093/infdis/jis383

J. Unsinger, M. Mcglynn, K. R. Kasten, A. S. Hoekzema, E. Watanabe et al., IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis, The Journal of Immunology, vol.184, issue.7, pp.3768-3779, 2010.
DOI : 10.4049/jimmunol.0903151

F. Venet, C. S. Chung, H. Kherouf, A. Geeraert, C. Malcus et al., )) contribute to lymphocyte anergy in septic shock patients, CD4(+)CD25 (+), pp.678-686, 2009.

T. M. Nunnally, M. E. Townsend, S. R. Reinhart, K. Kleinpell, R. M. Angus et al., Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, Crit. Care Med, vol.41, pp.2012-580, 2013.

F. Venet, A. C. Lukaszewicz, D. Payen, R. Hotchkiss, and G. Monneret, Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies, Current Opinion in Immunology, vol.25, issue.4, pp.477-483, 2013.
DOI : 10.1016/j.coi.2013.05.006

G. Dupont, J. Demaret, F. Venet, F. Malergue, C. Malcus et al., Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3??? cells versus regulatory T cells: A whole blood perspective, Cytokine, vol.69, issue.1, pp.146-149, 2014.
DOI : 10.1016/j.cyto.2014.05.021

R. S. Hotchkiss, C. M. Coopersmith, J. E. Mcdunn, and T. A. Ferguson, The sepsis seesaw: tilting toward immunosuppression, Nature Medicine, vol.177, issue.5, pp.496-497, 2009.
DOI : 10.1073/pnas.0809422106

R. S. Hotchkiss and S. Opal, Immunotherapy for Sepsis ??? A New Approach against an Ancient Foe, New England Journal of Medicine, vol.363, issue.1, pp.87-89, 2010.
DOI : 10.1056/NEJMcibr1004371

R. S. Hotchkiss, G. Monneret, and D. Payen, Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach, The Lancet Infectious Diseases, vol.13, issue.3, pp.260-268, 2013.
DOI : 10.1016/S1473-3099(13)70001-X

O. Alpdogan and M. R. Van-den-brink, IL-7 and IL-15: therapeutic cytokines for immunodeficiency, Trends in Immunology, vol.26, issue.1, pp.56-64, 2005.
DOI : 10.1016/j.it.2004.11.002

M. Morre and S. Beq, Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival, Targeted Oncology, vol.21, issue.10, pp.55-68, 2012.
DOI : 10.1007/s11523-012-0210-4

F. Kühlhorn, M. Rath, K. Schmoeckel, K. Cziupka, H. H. Nguyen et al., Foxp3+ Regulatory T Cells Are Required for Recovery from Severe Sepsis, PLoS ONE, vol.30, issue.5, p.65109, 2013.
DOI : 10.1371/journal.pone.0065109.s003

P. O. Scumpia, M. J. Delano, K. M. Kelly, K. A. O-'malley, P. A. Efron et al., Increased Natural CD4+CD25+ Regulatory T Cells and Their Suppressor Activity Do Not Contribute to Mortality in Murine Polymicrobial Sepsis, The Journal of Immunology, vol.177, issue.11, pp.7943-7949, 2006.
DOI : 10.4049/jimmunol.177.11.7943

W. Xiao, M. N. Mindrinos, J. Seok, J. Cuschieri, A. G. Cuenca et al., A genomic storm in critically injured humans, Inflammation and Host Response to Injury Large-Scale Collaborative Research Program, pp.2581-2590, 2011.
DOI : 10.1038/nature08780

K. Dellinger, R. Levy, M. Rhodes, A. Annane, D. Gerlach et al., Surviving Sepsis Campaign, Critical Care Medicine, vol.41, issue.2, pp.165-228, 2012.
DOI : 10.1097/CCM.0b013e31827e83af

M. Levy, A. Artigas, G. Phillips, A. Rhodes, R. Beale et al., Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study, The Lancet Infectious Diseases, vol.12, issue.12, pp.919-924, 2012.
DOI : 10.1016/S1473-3099(12)70239-6

D. Angus and T. Van-der-poll, Severe Sepsis and Septic Shock, New England Journal of Medicine, vol.369, issue.9, pp.840-851, 2013.
DOI : 10.1056/NEJMra1208623

R. Hotchkiss, G. Monneret, and D. Payen, Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach, The Lancet Infectious Diseases, vol.13, issue.3, pp.260-268, 2013.
DOI : 10.1016/S1473-3099(13)70001-X

R. Hotchkiss, G. Monneret, and D. Payen, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nature Reviews Immunology, vol.12, issue.12, pp.862-874, 2013.
DOI : 10.1038/nri3552

C. Guignant, F. Venet, S. Planel, J. Demaret, A. Gouel-cheron et al., Increased MerTK expression in circulating innate immune cells of patients with septic shock, Intensive Care Medicine, vol.37, issue.5, pp.1556-1564, 2013.
DOI : 10.1007/s00134-013-3006-9

D. Grimaldi, S. Louis, F. Pene, G. Sirgo, C. Rousseau et al., Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock, Intensive Care Medicine, vol.174, issue.9, pp.1438-1446, 2011.
DOI : 10.1007/s00134-011-2306-1

F. Venet, A. Lukaszewicz, D. Payen, R. Hotchkiss, and G. Monneret, Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies, Current Opinion in Immunology, vol.25, issue.4, pp.477-483, 2013.
DOI : 10.1016/j.coi.2013.05.006

R. Hotchkiss and S. Opal, Immunotherapy for Sepsis ??? A New Approach against an Ancient Foe, New England Journal of Medicine, vol.363, issue.1, pp.87-89, 2010.
DOI : 10.1056/NEJMcibr1004371

R. Hotchkiss, C. Coopersmith, J. Mcdunn, and T. Ferguson, The sepsis seesaw: tilting toward immunosuppression, Nature Medicine, vol.177, issue.5, pp.496-497, 2009.
DOI : 10.1073/pnas.0809422106

J. Unsinger, C. Burnham, J. Mcdonough, M. Morre, P. Prakash et al., Interleukin-7 Ameliorates Immune Dysfunction and Improves Survival in a 2-Hit Model of Fungal Sepsis, Journal of Infectious Diseases, vol.206, issue.4, pp.606-616, 2012.
DOI : 10.1093/infdis/jis383

J. Unsinger, H. Kazama, J. Mcdonough, T. Griffith, R. Hotchkiss et al., Sepsis-Induced Apoptosis Leads to Active Suppression of Delayed-Type Hypersensitivity by CD8+ Regulatory T Cells through a TRAIL-Dependent Mechanism, The Journal of Immunology, vol.184, issue.12, pp.6766-6772, 2010.
DOI : 10.4049/jimmunol.0904054

J. Unsinger, H. Kazama, J. Mcdonough, R. Hotchkiss, and T. Ferguson, Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury, Journal of Leukocyte Biology, vol.85, issue.3, 2009.
DOI : 10.1189/jlb.0808491

K. Kasten, P. Prakash, J. Unsinger, H. Goetzman, L. England et al., Interleukin-7 (IL-7) Treatment Accelerates Neutrophil Recruitment through ???? T-Cell IL-17 Production in a Murine Model of Sepsis, Infection and Immunity, vol.78, issue.11, pp.4714-4722, 2010.
DOI : 10.1128/IAI.00456-10

C. Mackall, T. Fry, and R. Gress, Harnessing the biology of IL-7 for therapeutic application, Nature Reviews Immunology, vol.44, issue.5, pp.330-342, 2011.
DOI : 10.1038/nri2970

F. Venet, A. Foray, A. Villars-mechin, C. Malcus, F. Poitevin-later et al., IL-7 Restores Lymphocyte Functions in Septic Patients, The Journal of Immunology, vol.189, issue.10, pp.5073-5081, 2012.
DOI : 10.4049/jimmunol.1202062

V. Badot, R. Luijten, J. Van-roon, G. Depresseux, S. Aydin et al., Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.72, issue.3, pp.453-456, 2013.
DOI : 10.1136/annrheumdis-2012-202364

P. Monti, C. Brigatti, M. Krasmann, A. Ziegler, and E. Bonifacio, Concentration and Activity of the Soluble Form of the Interleukin-7 Receptor ?? in Type 1 Diabetes Identifies an Interplay Between Hyperglycemia and Immune Function, Diabetes, vol.62, issue.7, pp.2500-2508, 2013.
DOI : 10.2337/db12-1726

W. Lundstrom, S. Highfill, S. Walsh, S. Beq, E. Morse et al., Soluble IL7R?? potentiates IL-7 bioactivity and promotes autoimmunity, Proceedings of the National Academy of Sciences, vol.110, issue.19, pp.1761-1770, 2013.
DOI : 10.1073/pnas.1222303110

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651437

R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM Consensus Conference Committee, pp.1644-1655, 1992.
DOI : 10.1378/chest.101.6.1644

G. Monneret, F. Venet, A. Pachot, and A. Lepape, Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony, Mol Med, vol.14, pp.64-78, 2008.

C. Meisel, J. Schefold, R. Pschowski, T. Baumann, K. Hetzger et al., Granulocyte???Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.7, pp.640-648, 2009.
DOI : 10.1164/rccm.200903-0363OC

C. Pleiman, S. Gimpel, L. Park, H. Harada, T. Taniguchi et al., Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter., Molecular and Cellular Biology, vol.11, issue.6, pp.3052-3059, 1991.
DOI : 10.1128/MCB.11.6.3052

A. Crawley and J. Angel, The influence of HIV on CD127 expression and its potential implications for IL-7 therapy, Seminars in Immunology, vol.24, issue.3, pp.231-240, 2012.
DOI : 10.1016/j.smim.2012.02.006

A. Crawley, S. Faucher, and J. Angel, Soluble IL-7R?? (sCD127) Inhibits IL-7 Activity and Is Increased in HIV Infection, The Journal of Immunology, vol.184, issue.9, pp.4679-4687, 2010.
DOI : 10.4049/jimmunol.0903758

F. Mckay, L. Swain, S. Schibeci, J. Rubio, T. Kilpatrick et al., Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis, Genes and Immunity, vol.176, issue.1, pp.1-6, 2008.
DOI : 10.1002/1531-8249(200006)47:6<831::AID-ANA21>3.3.CO;2-8

A. Korte, J. Kochling, L. Badiali, C. Eckert, J. Andreae et al., EXPRESSION ANALYSIS AND CHARACTERIZATION OF ALTERNATIVELY SPLICED TRANSCRIPTS OF HUMAN IL-7R?? CHAIN ENCODING TWO TRUNCATED RECEPTOR PROTEINS IN RELAPSED CHILDHOOD ALL, Cytokine, vol.12, issue.11, pp.1597-1608, 2000.
DOI : 10.1006/cyto.2000.0777

A. Gouel-cheron, B. Allaouchiche, C. Guignant, F. Davin, B. Floccard et al., Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma Predisposition, insult/infection, response, and organ dysfunction: a new model for staging severe sepsis, PLoS One Crit Care Med, vol.7, issue.37, pp.1329-1335, 2009.

D. Annane, P. Aegerter, and M. Jars-guincestre, Current Epidemiology of Septic Shock, American Journal of Respiratory and Critical Care Medicine, vol.168, issue.2, pp.165-72, 2003.
DOI : 10.1164/rccm.2201087

J. Quenot, C. Binquet, and F. Kara, The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study, Critical Care, vol.17, issue.2, p.65, 2013.
DOI : 10.1186/cc12598

URL : https://hal.archives-ouvertes.fr/inserm-00873494

M. Levy, A. Artigas, and G. Phillips, Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study, The Lancet Infectious Diseases, vol.12, issue.12, pp.919-943, 2012.
DOI : 10.1016/S1473-3099(12)70239-6

D. Angus and T. Van-der-poll, Severe Sepsis and Septic Shock, New England Journal of Medicine, vol.369, issue.9, pp.840-51, 2013.
DOI : 10.1056/NEJMra1208623

R. Hotchkiss, G. Monneret, and D. Payen, Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach, The Lancet Infectious Diseases, vol.13, issue.3, pp.260-268, 2013.
DOI : 10.1016/S1473-3099(13)70001-X

F. Venet, A. Lukaszewicz, and D. Payen, Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies, Current Opinion in Immunology, vol.25, issue.4, pp.477-83, 2013.
DOI : 10.1016/j.coi.2013.05.006

B. Amulic, C. Cazalet, and G. Hayes, Neutrophil Function: From Mechanisms to Disease, Annual Review of Immunology, vol.30, issue.1, pp.459-89, 2012.
DOI : 10.1146/annurev-immunol-020711-074942

A. Segal, HOW NEUTROPHILS KILL MICROBES, Annual Review of Immunology, vol.23, issue.1, pp.197-223, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115653

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2092448

M. Kaplan, M. Radic, J. Pillay, V. Kamp, and E. Van-hoffen, Neutrophil extracellular traps: double-edged swords of innate immunity [10] Hofman P. Molecular regulation of neutrophil apoptosis and potential targets for therapeutic strategy against the inflammatory process, A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1, pp.2689-951, 2004.

M. Gresnigt, L. Joosten, and I. Verschueren, Neutrophilmediated inhibition of proinflammatory cytokine responses [13] Hoffmann JJ. Neutrophil CD64: a diagnostic marker for infection and sepsis, J Clin Invest J Immunol. Clin Chem Lab Med, vol.1221218947, issue.1108, pp.327-364806, 2009.

M. Kobold, A. Tulleken, J. Zijlstra, and J. , Leukocyte activation in sepsis; correlations with disease state and mortality Combination biomarkers to diagnose sepsis in the critically ill patient, The ACCP-SCCM consensus conference on sepsis and organ failure, pp.883-9265, 1992.

A. Nierhaus, S. Klatte, and J. Linssen, Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis - a prospective, observational study, BMC Immunology, vol.14, issue.1
DOI : 10.1007/BF01709751

G. Drifte, I. Dunn-siegrist, and P. Tissieres, Innate Immune Functions of Immature Neutrophils in Patients With Sepsis and Severe Systemic Inflammatory Response Syndrome*, Critical Care Medicine, vol.41, issue.3, pp.820-852, 2013.
DOI : 10.1097/CCM.0b013e318274647d

L. Fialkow, F. Filho, L. Bozzetti, and M. , Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome, Critical Care, vol.10, issue.6, p.155, 2006.
DOI : 10.1186/cc5090

E. Tamayo, E. Gomez, and J. Bustamante, Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors, Journal of Critical Care, vol.27, issue.4, pp.415-416, 2011.
DOI : 10.1016/j.jcrc.2011.09.001

A. Chishti, B. Shenton, and J. Kirby, Neutrophil chemotaxis and receptor expression in clinical septic shock, Intensive Care Medicine, vol.30, issue.4, pp.605-616, 2004.
DOI : 10.1007/s00134-004-2175-y

P. Martins, M. Brunialti, and L. Martos, Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis, Critical Care, vol.12, issue.1, p.25, 2008.
DOI : 10.1186/cc6801

B. Tavares-murta, M. Zaparoli, and R. Ferreira, Failure of neutrophil chemotactic function in septic patients*, Critical Care Medicine, vol.30, issue.5, pp.1056-61, 2002.
DOI : 10.1097/00003246-200205000-00017

P. Martins, E. Kallas, and M. Neto, Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients Immature circulating neutrophils in sepsis have impaired phagocytosis and calcium signaling Neutrophil extracellular traps kill bacteria Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice Neutrophils in development of multiple organ failure in sepsis Human suppressive neutrophils CD16bright/CD62Ldim exhibit decreased adhesion Modulation of granulocyte kinetics by GM-CSF/IFN-gamma in a human LPS rechallenge model Myeloid-derived suppressor cells control microbial sepsis, human neutrophils during severe sepsis and septic shockR137. [29], pp.208-12315, 2002.

. Fluorescein-isothiocyanate, Phycoerythrin (PE)-labeled anti-myeloperoxidase (MPO ? clone CLB-MPO-1) and anti-lactoferrin (clone CLB 13, p.17

. First, stimulate blood samples (100?l of whole blood) with increasing hIL-2 or rhIL-7 concentrations (vortex immediately after adding the cytokine) at 37°C in a water bath for 10 min

R. 1. Maecker, H. Mccoy, J. Nussenblatt, and R. , Standardizing immunophenotyping for the Human Immunology Project, Nat Rev Immunol, vol.12, pp.191-200, 2012.

J. Robinson and M. Roederer, Flow cytometry strikes gold, Science, vol.350, issue.6262, pp.739-779, 2015.
DOI : 10.1126/science.aad6770

O. Perez, D. Mitchell, R. Campos, G. Gao, L. Li et al., Multiparameter Analysis of Intracellular Phosphoepitopes in Immunophenotyped Cell Populations by Flow Cytometry, Curr Protoc Cytom Chapter, vol.98, p.20, 2005.
DOI : 10.1002/0471142956.cy0620s32

F. Venet, C. Guignant, and G. Monneret, Flow Cytometry Developments and Perspectives in Clinical Studies: Examples in ICU Patients, Methods Mol Biol, vol.761, pp.261-75, 2011.
DOI : 10.1007/978-1-61779-182-6_18

M. Levy, A. Artigas, G. Phillips, A. Rhodes, R. Beale et al., Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study, The Lancet Infectious Diseases, vol.12, issue.12, pp.919-943, 2012.
DOI : 10.1016/S1473-3099(12)70239-6

R. Hotchkiss, G. Monneret, and D. Payen, Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach, The Lancet Infectious Diseases, vol.13, issue.3, pp.260-268, 2013.
DOI : 10.1016/S1473-3099(13)70001-X

R. Hotchkiss, G. Monneret, and D. Payen, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nature Reviews Immunology, vol.12, issue.12, pp.862-74, 2013.
DOI : 10.1038/nri3552

F. Venet, A. Lukaszewicz, D. Payen, R. Hotchkiss, and G. Monneret, Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies, Current Opinion in Immunology, vol.25, issue.4, pp.477-83, 2013.
DOI : 10.1016/j.coi.2013.05.006

G. Monneret, F. Venet, A. Pachot, and A. Lepape, Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony, Mol Med, vol.14, pp.64-78, 2008.

C. Mackall, T. Fry, and R. Gress, Harnessing the biology of IL-7 for therapeutic application, Nature Reviews Immunology, vol.44, issue.5, pp.330-372, 2011.
DOI : 10.1038/nri2970

F. Venet, A. Foray, A. Villars-mechin, C. Malcus, F. Poitevin-later et al., IL-7 Restores Lymphocyte Functions in Septic Patients, The Journal of Immunology, vol.189, issue.10, pp.5073-81, 2012.
DOI : 10.4049/jimmunol.1202062

B. Amulic, C. Cazalet, G. Hayes, K. Metzler, and A. Zychlinsky, Neutrophil Function: From Mechanisms to Disease, Annual Review of Immunology, vol.30, issue.1, pp.459-89, 2012.
DOI : 10.1146/annurev-immunol-020711-074942

J. Pillay, V. Kamp, E. Van-hoffen, T. Visser, T. Tak et al., A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1, Journal of Clinical Investigation, vol.122, issue.1, pp.327-363, 2012.
DOI : 10.1172/JCI57990DS1

E. Guerin, M. Orabona, M. Raquil, B. Giraudeau, R. Bellier et al., Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration*, Critical Care Medicine, vol.42, issue.9, pp.2007-2025, 2014.
DOI : 10.1097/CCM.0000000000000344

J. Demaret, F. Venet, A. Friggeri, M. Cazalis, J. Plassais et al., Marked alterations of neutrophil functions during sepsis-induced immunosuppression Lactoferrin for prevention of neonatal sepsis, J Leukoc Biol Biometals, vol.17, issue.27, pp.1007-1023, 2014.

S. Klebanoff, Myeloperoxidase: friend and foe, Journal of Leukocyte Biology, vol.77, issue.5, pp.598-625, 2005.
DOI : 10.1189/jlb.1204697

V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann et al., Neutrophil Extracellular Traps Kill Bacteria, Science, vol.303, issue.5663, pp.1532-1537, 2004.
DOI : 10.1126/science.1092385

H. Parker, A. Albrett, A. Kettle, and C. Winterbourn, Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide, Journal of Leukocyte Biology, vol.91, issue.3, pp.369-76, 2013.
DOI : 10.1189/jlb.0711387

C. Baecher-allan and D. Hafler, Human regulatory T cells and their role in autoimmune disease, Immunological Reviews, vol.172, issue.1, pp.203-219, 2006.
DOI : 10.1084/jem.20032069

K. Wood, A. Bushell, and J. Hester, Regulatory immune cells in transplantation, Nature Reviews Immunology, vol.21, issue.6, pp.417-447, 2012.
DOI : 10.1038/nri3227

G. Monneret and F. Venet, Additional bad news from regulatory T cells in sepsis, Critical Care, vol.14, issue.6, 2010.
DOI : 10.1186/cc9357

URL : http://doi.org/10.1186/cc9357

D. Amani, Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC), Lung Cancer, vol.77, pp.306-317, 2012.

T. Fukaya, H. Takagi, Y. Sato, K. Sato, K. Eizumi et al., Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance, Blood, vol.116, issue.13, pp.2266-76, 2010.
DOI : 10.1182/blood-2009-10-250472

URL : https://hal.archives-ouvertes.fr/hal-00605852

S. Sakaguchi, M. Miyara, C. Costantino, and D. Hafler, FOXP3+ regulatory T cells in the human immune system, Nature Reviews Immunology, vol.34, issue.7, pp.490-500, 2010.
DOI : 10.1038/nri2785

J. Saison, J. Demaret, F. Venet, C. Chidiac, C. Malcus et al., CD4+CD25+CD127??? assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects, Cytometry Part B: Clinical Cytometry, vol.130, issue.1, 2012.
DOI : 10.1002/cyto.b.21047

J. Demaret, J. Saison, F. Venet, C. Malcus, F. Poitevin-later et al., Assessment of a novel flow cytometry technique of one-step intracellular staining: Example of FOXP3 in clinical samples, Cytometry Part B: Clinical Cytometry, vol.110, issue.3, pp.187-93, 2013.
DOI : 10.1002/cyto.b.21070

A. Kretzschmar, M. Dinger, C. Henze, K. Brocke-heidrich, and F. Horn, Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells, Biochemical Journal, vol.377, issue.2, pp.289-97, 2004.
DOI : 10.1042/bj20030708

N. Cella, B. Groner, and N. Hynes, Characterization of Stat5a and Stat5b Homodimers and Heterodimers and Their Association with the Glucocortiocoid Receptor in Mammary Cells, Molecular and Cellular Biology, vol.18, issue.4, pp.1783-92, 1998.
DOI : 10.1128/MCB.18.4.1783

O. Perez and G. Nolan, Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level, Immunological Reviews, vol.18, issue.1, pp.208-236, 2006.
DOI : 10.1161/01.CIR.0000121563.47232.2A

G. Dupont, J. Demaret, F. Venet, F. Malergue, C. Malcus et al., Comparative dose-responses of recombinant human IL-2, p.7, 2014.

Y. Rochman, R. Spolski, and W. Leonard, New insights into the regulation of T cells by ??c family cytokines, Nature Reviews Immunology, vol.223, issue.7, pp.480-90, 2009.
DOI : 10.1038/nri2580

M. Atkins, Interleukin-2: Clinical applications, Seminars in Oncology, vol.29, issue.3, pp.12-19, 2002.
DOI : 10.1053/sonc.2002.33077

J. Demaret, G. Dupont, F. Venet, A. Friggeri, A. Lepape et al., STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study, Journal of Leukocyte Biology, vol.97, issue.4, pp.791-797, 2015.
DOI : 10.1189/jlb.5AB1114-545R